296 related articles for article (PubMed ID: 12466244)
21. Cysteinyl leukotriene receptor assays.
Muccitelli RM; Luttmann MA; Hay DW
Curr Protoc Pharmacol; 2001 May; Chapter 4():Unit 4.16. PubMed ID: 22293965
[TBL] [Abstract][Full Text] [Related]
22. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
23. Functional studies of leukotriene receptors in vascular tissues.
Walch L; Norel X; Gascard JP; Brink C
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
27. Agonist and antagonist activities of the leukotriene analogue BAY u9773 in guinea pig lung parenchyma.
Wikström Jonsson E; Rosenqvist U; Dahlén SE
Eur J Pharmacol; 1998 Sep; 357(2-3):203-11. PubMed ID: 9797038
[TBL] [Abstract][Full Text] [Related]
28. The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
Bouchelouche K; Andersen L; Nordling J; Horn T; Bouchelouche P
J Urol; 2003 Aug; 170(2 Pt 1):638-44. PubMed ID: 12853847
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
30. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
31. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
32. Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).
Chebolu S; Wang Y; Ray AP; Darmani NA
Eur J Pharmacol; 2010 Feb; 628(1-3):195-201. PubMed ID: 19941848
[TBL] [Abstract][Full Text] [Related]
33. Molecular and functional aspects of human cysteinyl leukotriene receptors.
Capra V
Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
[TBL] [Abstract][Full Text] [Related]
34. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
Jonsson EW
Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
[TBL] [Abstract][Full Text] [Related]
37. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene receptors on human pulmonary vascular endothelium.
Ortiz JL; Gorenne I; Cortijo J; Seller A; Labat C; Sarria B; Abram TS; Gardiner PJ; Morcillo E; Brink C
Br J Pharmacol; 1995 Aug; 115(8):1382-6. PubMed ID: 8564195
[TBL] [Abstract][Full Text] [Related]
39. Cysteinyl leukotriene-dependent [Ca2+]i responses to angiotensin II in cardiomyocytes.
Liu P; Misurski DA; Gopalakrishnan V
Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1269-76. PubMed ID: 12531730
[TBL] [Abstract][Full Text] [Related]
40. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
